PROOF AT THE SPEED OF LIFE
LIVE

Serial Number

90399406

Owner

SIGNANT HEALTH GLOBAL LLC

Attorney

Anna Kurian Shaw

First Use Date

Apr 30, 2021

Filing Date

Dec 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PROOF AT THE SPEED OF LIFE Trademark

Serial Number: 90399406 • Registration: 8380331

PROOF AT THE SPEED OF LIFE is a trademark filed by SIGNANT HEALTH GLOBAL LLC on December 21, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

SIGNANT HEALTH GLOBAL LLC (20 trademarks)

785 ARBOR WAY
BLUE BELL, PA 19422

Entity Type: 16

Bracket Global LLC

785 Arbor Way
Blue Bell, PA 19422

Entity Type: 16

Trademark Details

Filing Date

December 21, 2020

Registration Date

August 4, 2026

First Use Anywhere

April 30, 2021

First Use in Commerce

April 30, 2021

Published for Opposition

January 7, 2025

Goods & Services

Providing temporary use of non-downloadable software and applications for use in database management and support for use in data collection in connection with clinical trials, telemedicine for clinical trials, and remote site monitoring; medical and scientific research, data collection and data analysis in the nature of conducting clinical research and clinical trials for others in the fields of health care, medical care and pharmaceutical use; provision of an internet based database in the field of medical research for data entry and management; development of customized software for others for use in audit in the nature of electronic approval and audit trail capture in the field of pharmaceutical research and development designed to facilitate complex statistical techniques; programming of computer software for others featuring programming technologies and validation procedures to support subject screening, randomization, trial supply management, site management and electronic patient reported outcomes and registries; providing an internet based database in the field of medical research for data entry and management, providing an internet based database in the field of medical research for data entry and management, development of customized software for others for use in audit, namely, software for electronic approval and audit trail capture to conduct clinical trials in the field of clinical trials for pharmaceutical research; and development design and development of computer software relating to the field of clinical trials; application service provider (ASP) featuring software for use in data collection, data integration, data analytics, data reporting, database management, and project management;, provision of search platforms in the nature of temporary online non-downloadable software to manage diabetes management data; software as a service (SAAS) services featuring software for hosting, managing, and transmitting patient data and communicating with patients via video consults, messaging and surveys; software as a service (SAAS) services featuring software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, all of which information is added to existing study questionnaires as a way to record concomitant medications; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of clinical outcomes assessments on web based, short message service, and mobile devices; software as a service (SAAS) services featuring software for conveying to patients information related to a clinical trial using interactive multimedia and for enabling patients to dynamically engage, review, question and agree to participate in a clinical trial, software as a service (SAAS) services featuring software for enabling patients to enroll in a clinical study; software as a service (SAAS) services featuring software for enabling users to view, manage and report on patient reported data in pharmaceutical industry clinical trials; software as a service (SAAS) services featuring software for the development, design, localization and simulation of electronic clinical outcome assessments for pharmaceutical industry clinical trials; consulting services in the design and implementation of computer based information systems related to clinical trial and supply management for businesses; software as a service (SAAS) services for computers and mobile devices featuring telemedicine software for clinical trials, remote site monitoring software, patient engagement and communication software, pharmaceutical industry clinical trial software, drug supply software, data analytics and reporting software, clinical data collection software, clinical trial patient monitoring software, patient engagement and communication software, pharmaceutical industry clinical trial software, clinical trial management software, clinical trial patient monitoring software, data integration and transmission software, clinical trial audio visual software, patient consenting software pharmaceutical industry clinical trial software, randomisation software, drug supply software, data analytics and reporting software, clinical data collection software

BUSINESS CONSULTING AND MANAGEMENT SERVICES IN THE FIELD OF CLINICAL TRIALS, MANAGEMENT AND COMPILATION OF COMPUTERIZED DATABASES IN THE FIELD OF CLINICAL TRIALS, namely, CUSTOMIZE RATINGS RELIABILITY ACTIVITIES; PROVIDING AN INTERNET BASED DATABASE FOR BUSINESS PURPOSES DESIGNED TO FACILITATE COMPLEX STATISTICAL TECHNIQUES, PROGRAMMING TECHNOLOGIES AND VALIDATION PROCEDURES TO SUPPORT SUBJECT SCREENING, RANDOMIZATION, TRIAL SUPPLY MANAGEMENT, SITE MANAGEMENT AND ELECTRONIC PATIENT REPORTED OUTCOMES AND REGISTRIES; PROVIDING AN INTERNET BASED DATABASE IN THE FIELD OF CLINICAL TRIALS FOR BUSINESS PURPOSES FEATURING BUSINESS INFORMATION; PROVIDING AN INTERNET BASED DATABASE IN THE FIELD OF CLINICAL TRIALS FOR BUSINESS PURPOSES BUSINESS CONSULTING SERVICES PROVIDED TO PHARMACEUTICAL INDUSTRY CLIENTS INVOLVED IN PHASE I, II AND III TRIALS; BUSINESS CONSULTING AND MANAGEMENT IN THE FIELD OF CLINICAL TRIALS, namely, VIDEO ENHANCEMENT OF RATER INTERVIEWING FOR INDEPENDENT EVALUATION DATA

Medical training, namely, training of staff in administering medicine and testing, completing patient documentation, and using technology, in the field of pharmaceutical studies; provision of a website featuring temporary online non-downloadable publications in the nature of reports, articles and presentations in the fields of clinical trials; provision of temporary online non-downloadable educational webinars in the field of clinical trials

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 4, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 4, 2026 R.PR
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 20, 2026 EPPA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 15, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 15, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 10, 2026 SUPC
USE AMENDMENT FILED
Feb 26, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 26, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
Sep 2, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 2, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 2, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2024 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 8, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 25, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 25, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 5, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 20, 2022 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 13, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 13, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jan 13, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 15, 2021 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 16, 2021 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 16, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 16, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 16, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2021 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 8, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 8, 2021 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 24, 2020 NWAP